class="wp-theme-Newspaper supp-body td-standard-pack global-block-template-1 tdc-header-template tdc-footer-template td-animation-stack-type0 td-full-layout"
GI effects (gas, bloating) at higher doses. May reduce fat-soluble vitamin absorption. Generally safe. See Phase 2 excipients for full cyclodextrin profile.
Six-glucose ring cyclodextrin with dietary fibre characteristics. Reduces fat and carbohydrate absorption when taken with meals. E458. GRAS. Very low glycaemic impact.
Acts on cellular signalling pathways relevant to the documented clinical indications. Contains bioactive compounds with enzyme-modulating, receptor-binding, or antioxidant properties studied in peer-reviewed literature.
| Population | Safety rating | Max safe dose |
|---|---|---|
| General | Likely safe | — |
| Pregnancy | Likely safe | — |
| Elderly | Likely safe | — |
No peer-reviewed clinical trial data found for this ingredient.
Data by supplement.ge — Public Health Institute of Georgia (PHIG)